Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps

alexandrossfakianakis shared this article with you from Inoreader Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps Via Journal of Otolaryngology - Head & Neck Surgery - Latest Articles Dupilumab is the first monoclonal antibody therapy to be approved in Canada for the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). The goal of the study was to assess its effectiveness and eff... View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.